Organisation paid for research Program year 2025 Source: CMS Open Payments

Vitality Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$117,722

15 payments

Through program year 2025, Vitality Clinical Research is reported as receiving $117,722 in research payments, across 15 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $6,600 1
2024 Research $29,387 7
2023 Research $81,736 7

Breakdown

Who paid Research payments · program years 2023–2025
  1. Genzyme Corporation $59,870 11 payments
  2. Amgen Inc. $57,852 4 payments
Studies the money was for Research payments · program years 2023–2025
  1. A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma $59,870 11 payments
  2. Phase 3 - Cardiovascular Outcomes Trial $40,935 2 payments
  3. OCEANa-Outcomes P3 CV $16,918 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record